openPR Logo
Press release

RxSight, Inc. (NASDAQ: RXST) Investor Alert: Deadline in Lawsuit on September 22, 2025

A Deadline is coming up on September 22, 2025 in the lawsuit for certain investors in RxSight, Inc. (NASDAQ: RXST).

A Deadline is coming up on September 22, 2025 in the lawsuit for certain investors in RxSight, Inc. (NASDAQ: RXST).

A deadline is coming up on September 22, 2025 in the lawsuit filed for certain investors of RxSight, Inc. (NASDAQ: RXST) over alleged securities laws violations by RxSight, Inc.

Investors who purchased shares of RxSight, Inc. (NASDAQ: RXST) have certain options and there are strict and short deadlines running. Deadline: September 22, 2025. RxSight, Inc. (NASDAQ: RXST) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on behalf of purchasers of RxSight, Inc. (NASDAQ: RXST) common shares between November 7, 2024 and July 8, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 7, 2024 and July 8, 2025, the Defendants failed to disclose to investors that the Company was experiencing "adoption challenges" and/or structural issues resulting in declines in sales and utilization, that the Defendants had overstated the demand for RxSight's products, that as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of RxSight, Inc. (NASDAQ: RXST) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RxSight, Inc. (NASDAQ: RXST) Investor Alert: Deadline in Lawsuit on September 22, 2025 here

News-ID: 4168936 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Nutex Health Inc. (NASDAQ: NUTX)
Lawsuit filed for Investors who lost money with shares of Nutex Health Inc. (NAS …
An investor, who purchased shares of Nutex Health Inc. (NASDAQ: NUTX), filed a lawsuit over alleged violations of Federal Securities Laws by Nutex Health Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Nutex Health Inc. (NASDAQ: NUTX) have certain options and for certain investors are short and strict deadlines running. Deadline: October 21, 2025. NASDAQ: NUTX investors should contact the Shareholders Foundation at
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investor Alert: Deadline in Lawsuit on September 15, 2025
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investor Alert: Deadline in Lawsuit o …
A deadline is coming up on September 15, 2025 in the lawsuit filed for certain investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) over alleged securities laws violations by Capricor Therapeutics, Inc. Investors who purchased shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR) have certain options and there are strict and short deadlines running. Deadline: September 15, 2025. Capricor Therapeutics, Inc. (NASDAQ: CAPR) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call
Investigation announced for Long-Term Investors in shares of Tempus AI, Inc. (NASDAQ: TEM) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of Tempus AI, Inc. (NA …
An investigation was announced for current long-term investors in shares of Tempus AI, Inc. (NASDAQ: TEM) concerning potential breaches of fiduciary duties by certain directors and officers of Tempus AI, Inc.. Investors who are current long term investors in Tempus AI, Inc. (NASDAQ: TEM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long
Investigation announced for Long-Term Investors in shares of Red Cat Holdings, Inc. (NASDAQ: RCAT)
Investigation announced for Long-Term Investors in shares of Red Cat Holdings, I …
An investigation was announced for current long-term investors in shares of Red Cat Holdings, Inc. (NASDAQ: RCAT) concerning potential breaches of fiduciary duties by certain directors of Red Cat Holdings, Inc. Investors who are current long term investors in Red Cat Holdings, Inc. (NASDAQ: RCAT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long

All 5 Releases


More Releases for RxSight

Lawsuit filed for Investors who lost money with shares of RxSight, Inc. (NASDAQ: …
An investor, who purchased shares of RxSight, Inc. (NASDAQ: RXST), filed a lawsuit over alleged violations of Federal Securities Laws by RxSight, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of RxSight, Inc. (NASDAQ: RXST) have certain options and for certain investors are short and strict deadlines running. Deadline: September 22, 2025. NASDAQ: RXST investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Surging Myopia and Presbyopia Treatment Market: Insights on 7.9% CAGR, Contribut …
Surge in the Geriatric Population Intensifies the Need For Myopia and Presbyopia Treatment, Fueling Market Growth What Is The Projected Market Size Of The Global Myopia and Presbyopia Treatment Market And Its Growth Rate? •The Myopia and Presbyopia Treatment Market experienced substantial growth in recent years, with a market value of $21.04 billion in 2024, and is projected to reach $22.7 billion in 2025, growing at a compound annual growth rate (CAGR)
Intraocular Lens Global Market is Booming Across the Globe and Witness Huge Grow …
"The new report published by The Business Research Company, titled ""Intraocular Lens Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the intraocular lens market size has grown rapidly in recent years. It will grow from $4.93
Intraocular Lens Global Market Size, Share Report, Growth, Analysis, Key Players …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company presents an extensive market research report on the Intraocular Lens Global Market Report 2024 , furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges,
Intraocular Lens Market to Record $7.82 Billion by 2028 - Exclusive Research Rep …
According to Arizton's latest research report, the intraocular lens market will grow at a CAGR of 7.25% from 2022 to 2028. Download a Free Sample Report Now: https://www.arizton.com/request-sample/3726 The intraocular lens (IOL) market has seen advancements in both material and structural design. Refraction, diffraction, or the combination of two surface structures in the design of the optical structure allow for multiple motivations and produce sharp images at various distances. The
Latest Intraocular Lens Market Report- Rising Trend, Demand Opportunity and Deta …
Intraocular Lens Market report incorporates item types, market applications, geographic areas, and financial backers and providers. Intraocular Lens Market overall statistical surveying gives a complete investigation of the business for the figure time frame. In addition, Intraocular Lens Market examination incorporates a few divisions just as a full investigation of the market's patterns and critical determinants. Moreover, Intraocular Lens Market report assists you in overcoming the difficulties by applying